Technical analysis of Innate Pharma S.A. (IPHA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Innate Pharma S.A. is a biotechnology firm, founded in 1999 and headquartered in Marseille, France, that specializes in the discovery, development, and market introduction of therapeutic antibodies. The company primarily targets oncology indications across France and internationally, with some programs also addressing inflammatory diseases and viral infections.
Price Performance
| 1 month | -2.90% |
| 3 months | +11.05% |
| Year-to-date | +14.86% |
| 1 year | -1.95% |
| 3 years | -26.91% |
| 5 years | -75.19% |
52-Week Range
| 52-week High | $2.71 |
| 52-week Low | $1.17 |
| Avg Volume (90d) | 143K |
Technical Indicators
| SMA 50 | $1.97 |
| SMA 200 | $1.75 |
| Beta | 0.74 |
| 30-day Volatility (annualised) | 108.8% |
| Price vs SMA 50 | +2.2% |
| Price vs SMA 200 | +14.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.97 | |
| 2025-11 | $1.95 | -1.0% |
| 2025-12 | $1.75 | -10.3% |
| 2026-01 | $1.83 | +4.6% |
| 2026-02 | $1.72 | -6.0% |
| 2026-03 | $1.28 | -25.6% |
| 2026-04 | $1.44 | +12.5% |
| 2026-05 | $1.83 | +27.1% |
| 2026-06 | $1.84 | +0.5% |
| 2026-07 | $1.75 | -4.9% |
| 2026-08 | $2.17 | +24.0% |
| 2026-09 | $2.01 | -7.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $144M |
| 2026-09-14 | | $898M |
Price
| Price | $2.01 |
| Market Cap | $189M |
| Exchange | NASDAQ |
| Country | FR |
Valuation Ratios
| Price / Book | -6.93 |
| EV / EBITDA | -2.50 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -1.04 |
| Current Ratio | 1.27 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -11.35 |